Fluconazole Use in High-Risk Surgical Patients
Author Information
Author(s): Ho Kwok M, Lipman Jeffrey, Dobb Geoffrey J, Webb Steven AR
Primary Institution: Royal Perth Hospital, Australia
Hypothesis
Does prophylactic fluconazole reduce the incidence of candidaemia and hospital mortality in immunocompetent high-risk surgical patients?
Conclusion
Prophylactic fluconazole reduces the incidence of candidaemia but shows only a trend towards reducing hospital mortality.
Supporting Evidence
- Fluconazole was associated with a reduction in candidaemia (RR = 0.21).
- Fluconazole reduced the need for systemic amphotericin B (RR = 0.35).
- No significant increase in fluconazole-resistant fungi was observed.
Takeaway
Giving fluconazole to patients at high risk for fungal infections helps lower the chances of getting a specific type of infection called candidaemia.
Methodology
Meta-analysis of randomized controlled trials involving immunocompetent high-risk surgical patients.
Potential Biases
Potential publication bias and variability in trial quality.
Limitations
The study did not include a formal cost-effectiveness analysis and had variability in study protocols.
Participant Demographics
Immunocompetent high-risk surgical patients, mean age around 54 years.
Statistical Information
P-Value
0.01
Confidence Interval
0.06–0.72
Statistical Significance
p=0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website